Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing [Phase 4]
Phase 4 clinical trial update on the use of Buventol Easyhaler and Bufomix Easyhaler in methacholine challenge testing for asthma.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient [Phase 3]
Phase 3 clinical trial update for an inhaled budesonide/formoterol product in asthma has completed.
-
FDA approval · 2023-08-28FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for ProAir Digihaler (albuterol sulfate) from Teva Respiratory, LLC. The approval covers changes rel…
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Azithromycin Treatment for the Airway Microbiome in Asthma [Phase 2]
Phase 2 clinical trial investigating azithromycin for the airway microbiome in asthma has been terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: A Study of MG-K10 in Subjects With Asthma [Phase 1, Phase 2]
Clinical trial update for MG-K10 in asthma spanning Phase 1 and Phase 2, status currently unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma [Phase 1]
Phase 1 trial updating safety and tolerability of BI 894416 in adults with mild asthma.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: AQI and Childhood Asthma: an Intervention [NA]
A completed clinical trial evaluating an intervention related to AQI and childhood asthma with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller [Phase 2]
Phase 2 trial evaluating MTPS9579A in asthma patients requiring inhaled corticosteroids and a second controller has completed with results p…
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma [Phase 2]
Phase 2 study of CSJ117 in severe uncontrolled asthma terminated; results posted.
-
FDA approval · 2023-07-31FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast Sodium from Macleods Pharmaceuticals Limited, authorizing continued marketing of thi…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma [Phase 2]
A Phase 2 pharmacokinetic trial compares mometasone furoate alone versus in combination with indacaterol in pediatric asthma patients aged 6…
-
CLINICAL_TRIALS trial_result · 2023-07-14Clinical Trial Update: Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban [Phase 2]
Phase 2 trial investigating Ifetroban for aspirin-exacerbated respiratory disease (AERD) shows completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Health Effects of Secondhand Smoke Exposure in Outdoor Smoking Areas in Patients With COPD and Asthma ( TackSHSWP5 ) [NA]
Clinical trial studying health effects of secondhand smoke exposure in outdoor smoking areas for patients with COPD and asthma; study comple…
-
FDA approval · 2023-06-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental ANDA for Montelukast Sodium by Unichem Pharmaceuticals (USA), Inc., granting approval for its generic product. M…
-
FDA approval · 2023-06-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental ANDA for Montelukast Sodium from Unichem Pharmaceuticals (USA), Inc., adding a generic Montelukast Sodium produc…
-
FDA approval · 2023-06-26FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approves a supplemental application for montelukast sodium from Lannett Company, Inc., under ANDA200405, authorizing an updated generic …
-
FDA approval · 2023-06-23FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.)
FDA approved a supplemental application for ALBUTEROL SULFATE from Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. under an ANDA for a generic p…
-
FDA approval · 2023-06-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Montelukast Sodium submitted by Camber Pharmaceuticals, Inc., under the approved ANDA.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: A Study to Test if TEV-53275 is Effective in Relieving Asthma [Phase 2]
Phase 2 trial of TEV-53275 for asthma was terminated with results posted.
-
FDA approval · 2023-06-07FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Montelukast submitted by BluePoint Laboratories.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: In Vivo Efficacy of Salbutamol (Sandoz) Versus Salbutamol Ventolin (GSK) in Children With Asthma [Phase 3]
Phase 3 clinical trial comparing in vivo efficacy of Salbutamol from Sandoz versus Salbutamol Ventolin from GSK in children with asthma; sta…
-
FDA approval · 2023-05-28FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for albuterol sulfate from Sun Pharmaceutical Industries, updating the status of this generic produc…
-
FDA approval · 2023-05-26FDA Approved: TEZSPIRE — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for Tezspire (tezepelumab-ekko) from Amgen, updating the product label.
-
CLINICAL_TRIALS withdrawal · 2023-05-26Clinical Trial Update: Effect of Gly16Arg Polymorphism in ADRB2 Gene on Asthma Control in Children Receiving Long Acting Beta Agonists [Phase 4]
Phase 4 trial investigating ADRB2 Gly16Arg polymorphism impact on asthma control in children on long-acting beta agonists; study withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Targeted AntiBiotics for Chronic Pulmonary Diseases [Phase 4]
Phase 4 clinical trial update for targeted antibiotics in chronic pulmonary diseases has been terminated.